Target intelligence / Profile preview

Novel transcript, antisense to BST1 (ENSG00000294363)

Target
ENSG00000294363
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

ENSG00000294363 is annotated as a novel long non-coding RNA (lncRNA) transcript, transcribed in the antisense orientation to the BST1 gene[1][3][5]. lncRNAs typically do not encode proteins and may function in gene expression regulation, though the biological roles of many lncRNAs remain unclear. For this specific transcript, there is no evidence of protein-coding capability, therapeutic target relevance, or well-defined biological/disease roles in major gene, protein, or therapeutic target databases. It is not regarded as a conventional "target molecule" (e.g., receptor, enzyme, transporter)[3][5]. This entry is not a well-defined molecular target. It is not a receptor, enzyme, transporter, or a protein-coding gene. There is insufficient information to classify it as a druggable, disease-relevant, or mechanistically significant target; its physiological and pathological relevance is unknown. If you are seeking information about BST1 (bone marrow stromal antigen 1), that is a distinct protein-coding gene and a recognized target in immune and neurological research[9]. This "novel transcript, antisense to BST1" is simply an uncharacterized non-coding RNA overlapping the BST1 locus.

Other names
novel transcript, antisense to BST1
02

Biological functions

UnknownLncRNAs are often involved in gene regulation (general function, not specific to this transcript)
03

Disease associations

Not establishedListed in gene search results related to Parkinson’s disease (no direct evidence of association)

Beyond the preview

Go deeper on Novel transcript, antisense to BST1 (ENSG00000294363).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to BST1 (ENSG00000294363).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call